| Biogen Inc. | 245.0500 / -1.92% |
| Date/Time | 09/28 / 07:57 |
| Chg. / Chg.(%) | -4.8000 / -1.92% |
| Bid | 243.5000 / 50 |
| Ask | 244.0000 / 50 |
| Open | 245.0500 |
| Previous Close | 249.8500 |
| High | 245.0500 |
| Low | 245.0500 |
| Volume [EUR] | - |
| Volume [Units] | |
| Price fixings | 1 |
| ISIN | US09062X1037 |
| Security | IDP |
| Exchange | Quotrix |
| Type | Stock |
Other Exchanges
| Exchange | Last | Volume | |
|---|---|---|---|
| NASDAQ | 284.7100 |  |
785,380 |
| Cboe US | 284.77 | |
45,386 |
| IEX | 284.63 | |
25,068 |
| Moscow | 21,121.00 | 2,353 | |
| London Domes.. | 286.98 | |
868 |
| Xetra | 245.95 | |
610 |
| TradeGate | 246.050 | |
373 |
| Frankfurt | 245.7000 | |
100 |
| gettex | 244.950 | |
59 |
| Vienna Globa.. | 245.45 | |
35 |
| München | 249.65 | |
5 |
| Hamburg | 244.45 |  |
0 |
| Düsseldorf | 245.85 | |
0 |
| Berlin | 246.10 | |
0 |
| Hannover | 244.45 | |
0 |
| Stuttgart | 245.400 | |
0 |
| Quotrix | 245.0500 | |
|
| Lang & Schwa.. | 244.000 | |
|
| Mexico | 5,775.00 | |
167 |
News
- FDA Grants Catalyst Biosciences Orphan Drug Designation for MarzAA for the Treatment of Factor VII Deficiency
09/28/2021 / 22:01 - GlobeNewswire - Catalyst Biosciences to Present at the Cantor Global Healthcare Conference
09/24/2021 / 14:00 - GlobeNewswire - SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cassava Sciences, Inc. - SAVA
09/24/2021 / 02:54 - GlobeNewswire - Dow opens more than 200 pts higher after Fed calls
09/23/2021 / 15:31 - TeleTrader - Biogen R&D Day to Provide Overview of Diversified Pipeline and Capabilities with Potential for Multiple Novel Therapies in Neuroscience
09/21/2021 / 14:30 - GlobeNewswire
Personal area
Real-timeClick on 
to activate push quotes.
to activate push quotes.